Identification of a critical site in Wld(s): essential for Nmnat enzyme activity and axon-protective function
- PMID: 17207927
- DOI: 10.1016/j.neulet.2006.11.067
Identification of a critical site in Wld(s): essential for Nmnat enzyme activity and axon-protective function
Abstract
The chimeric Wld(s) protein consisting of the N-terminal 70 amino acids of Ufd2 and the complete sequence of nicotinamide mononucleotide adenylyltransferase1 (Nmnat1), delays Wallerian degeneration in Wld(s) mice. Although Nmnat1 enzyme activity was showed to be critical for the function of Wld(s) protein, the expected phenotype was not observed in Nmnat1 transgenic mice. To further check whether Nmnat1 enzyme activity is involved, we aligned sequences of eukaryotic Nmnats, and found that Phe in helix A is highly conserved not only in various species, but also in different homologues. The Phe is a residue located near to the highly conserved GXFXPX(T/H)XXH motif and resides in the same helix as the last His of this conserved motif. To investigate the role of the conserved Phe in Nmnat activity, we made the point mutation of Phe. The Phe28 mutation of mouse Nmnat1 in Wld(s) completely abolished its Nmnat enzyme activity. To study the role of mutant Wld(s) in axon degeneration, herpes viruses were packaged to infect cultured SCGs. We found that the mutant Wld(s) failed to protect axon degeneration from morphological changes, microtubule integration and neurofilament degradation. Therefore, we have identified a Phe residue that critical for both enzyme activity of Nmnat and the axon-protective function of Wld(s), and further confirmed that Nmnat1 enzyme activity is required in Wld(s) function.
Similar articles
-
Wallerian degeneration, wld(s), and nmnat.Annu Rev Neurosci. 2010;33:245-67. doi: 10.1146/annurev-neuro-060909-153248. Annu Rev Neurosci. 2010. PMID: 20345246 Free PMC article. Review.
-
NAD(+) and axon degeneration revisited: Nmnat1 cannot substitute for Wld(S) to delay Wallerian degeneration.Cell Death Differ. 2007 Jan;14(1):116-27. doi: 10.1038/sj.cdd.4401944. Epub 2006 Apr 28. Cell Death Differ. 2007. PMID: 16645633
-
Nmnat2 delays axon degeneration in superior cervical ganglia dependent on its NAD synthesis activity.Neurochem Int. 2010 Jan;56(1):101-6. doi: 10.1016/j.neuint.2009.09.007. Epub 2009 Sep 22. Neurochem Int. 2010. PMID: 19778564
-
Reducing expression of NAD+ synthesizing enzyme NMNAT1 does not affect the rate of Wallerian degeneration.FEBS J. 2011 Aug;278(15):2666-79. doi: 10.1111/j.1742-4658.2011.08193.x. Epub 2011 Jun 14. FEBS J. 2011. PMID: 21615689
-
Axon degeneration: Mechanisms and implications of a distinct program from cell death.Neurochem Int. 2010 Mar;56(4):529-34. doi: 10.1016/j.neuint.2010.01.013. Epub 2010 Feb 1. Neurochem Int. 2010. PMID: 20117162 Review.
Cited by
-
Wallerian degeneration: an emerging axon death pathway linking injury and disease.Nat Rev Neurosci. 2014 Jun;15(6):394-409. doi: 10.1038/nrn3680. Nat Rev Neurosci. 2014. PMID: 24840802 Review.
-
Wallerian degeneration, wld(s), and nmnat.Annu Rev Neurosci. 2010;33:245-67. doi: 10.1146/annurev-neuro-060909-153248. Annu Rev Neurosci. 2010. PMID: 20345246 Free PMC article. Review.
-
Divergent signaling requirements of dSARM in injury-induced degeneration and developmental glial phagocytosis.PLoS Genet. 2022 Jun 23;18(6):e1010257. doi: 10.1371/journal.pgen.1010257. eCollection 2022 Jun. PLoS Genet. 2022. PMID: 35737721 Free PMC article.
-
Laser-based single-axon transection for high-content axon injury and regeneration studies.PLoS One. 2011;6(11):e26832. doi: 10.1371/journal.pone.0026832. Epub 2011 Nov 2. PLoS One. 2011. PMID: 22073205 Free PMC article.
-
Nicotinamide mononucleotide adenylyl transferase-mediated axonal protection requires enzymatic activity but not increased levels of neuronal nicotinamide adenine dinucleotide.J Neurosci. 2009 Apr 29;29(17):5525-35. doi: 10.1523/JNEUROSCI.5469-08.2009. J Neurosci. 2009. PMID: 19403820 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources